2011
DOI: 10.1016/s0022-510x(11)70002-8
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune disease in the brain – how to spot the culprits and how to keep them in check

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2014
2014
2016
2016

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 91 publications
0
2
0
Order By: Relevance
“…In recent years, several different migratory routes for immune cells over different cellular barriers into the CNS parenchyma have been characterized (Engelhardt and Sorokin, 2009; Wilson et al, 2010; Larochelle et al, 2011; Engelhardt and Ransohoff, 2012; Alvarez et al, 2013). However, the precise molecular mechanism responsible for homeostatic CNS immune surveillance and how inflammatory processes differ from regulatory/homeostatic processes on the immune cell side remain unclear (Flügel et al, 2011). Pressure to advance knowledge on the mechanisms of trans-endothelial diapedesis arose with the approval of therapeutic monoclonal antibodies interfering with cell trafficking.…”
mentioning
confidence: 99%
“…In recent years, several different migratory routes for immune cells over different cellular barriers into the CNS parenchyma have been characterized (Engelhardt and Sorokin, 2009; Wilson et al, 2010; Larochelle et al, 2011; Engelhardt and Ransohoff, 2012; Alvarez et al, 2013). However, the precise molecular mechanism responsible for homeostatic CNS immune surveillance and how inflammatory processes differ from regulatory/homeostatic processes on the immune cell side remain unclear (Flügel et al, 2011). Pressure to advance knowledge on the mechanisms of trans-endothelial diapedesis arose with the approval of therapeutic monoclonal antibodies interfering with cell trafficking.…”
mentioning
confidence: 99%
“…This brief overview of the pathologic lesions involved in the MS brain strongly suggests that there exists a widespread progressive neurodegenerative disease in which persistent inflammation plays a prominent role. It is very likely that there is an autoimmune component to this persistent inflammation, although specific autoreactive targets have not been well delineated [41] and immunotherapy of MS does not prevent disease progression in a substantial number of patients [42].…”
Section: Journal Of Neurology and Neurophysiologymentioning
confidence: 99%